Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04709679 · ClinicalTrials.gov registry record · NA
Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation
A NA study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04709679: Clinical Trial NA study, sponsored by State University of New York at Buffalo.
NCT04709679 is a NA study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04709679, a NA study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a prospective study to evaluate the clinical outcome of varying doses of Micropulse TransScleral CycloPhotocoagulation (MP-TSCPC) laser in patients with glaucoma. The study will assess documented complication rates, changes in visual acuity after the procedure, changes in intraocular pressures and medication drop usage, and need for subsequent treatments (including further laser or surgery).
Primary Outcome
Baseline (pre-operative condition) and post operative intraocular pressure will be measured on Day1, Week1, Months 1, 3, 6, 12, 18 and 24.
Interventions
- PROCEDURE MicroPulse TransScleral CycloPhotoCoagulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-10-11 |
| Phase | NA |
Why NCT04709679 stopped before completion
NCT04709679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which MicroPulse TransScleral CycloPhotoCoagulation is the first listed.
NCT04709679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04709679 about?
NCT04709679 is a clinical study titled "Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation". This is a prospective study to evaluate the clinical outcome of varying doses of Micropulse TransScleral CycloPhotocoagulation (MP-TSCPC) laser in patients with glaucoma. The study will assess documented complication rates, changes in visual acuity after the procedure, changes in intraocular pressur...
What is the current status of trial NCT04709679?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-01-01. Estimated completion is 2021-10-11.
What interventions are being tested in trial NCT04709679?
The interventions under investigation include: MicroPulse TransScleral CycloPhotoCoagulation (PROCEDURE).
Who is sponsoring clinical trial NCT04709679?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04709679's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI